Jhs Chemi Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-07-2024
- Paid Up Capital ₹ 0.96 M
as on 09-07-2024
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.25 Cr
as on 09-07-2024
- Satisfied Charges ₹ 9.30 Cr
as on 09-07-2024
- Revenue 21.39%
(FY 2021)
- Profit 42.35%
(FY 2021)
- Ebitda 32.21%
(FY 2021)
- Net Worth 61.48%
(FY 2021)
- Total Assets 37.16%
(FY 2021)
About Jhs Chemi Pharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.96 M.
The company currently has active open charges totaling ₹6.25 Cr. The company has closed loans amounting to ₹9.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Krutarth Shah, Neel Shah, Vaibhav Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH2004PTC148176
- Company No.
148176
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jhs Chemi Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaibhav Shah  | Director | 10-May-2011 | Current |
| Krutarth Shah | Director | 20-Dec-2008 | Current |
| Neel Shah | Director | 07-May-2008 | Current |
| Ramachandra Misra | Director | 07-May-2008 | Current |
Financial Performance of Jhs Chemi Pharma.
Jhs Chemi Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 21.39% increase. The company also saw a substantial improvement in profitability, with a 42.35% increase in profit. The company's net worth Soared by an impressive increase of 61.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jhs Chemi Pharma?
In 2021, Jhs Chemi Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sang-Deep Acid-Chem Private LimitedActive 31 years 4 monthsKrutarth Shah and Neel Shah are mutual person
Mishri Solvochem Private LimitedActive 17 years 3 monthsNeel Shah and Ramachandra Misra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Jul 2022 | ₹6.25 Cr | Open |
Hdfc Bank Limited Creation Date: 01 Jun 2019 | ₹3.62 Cr | Satisfied |
Others Creation Date: 26 Sep 2017 | ₹2.27 Cr | Satisfied |
How Many Employees Work at Jhs Chemi Pharma?
Jhs Chemi Pharma has a workforce of 30 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jhs Chemi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jhs Chemi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
